Vitamin D Roles Across Developmental Stages in Pediatric Pneumonia: Linking Genetics, Microbiome, Maternal Status and
1Department of Biochemistry and Molecular Biology Shahjalal University of Science and Technology Sylhet Bangladesh.
Insights
Vitamin D plays a crucial role in pediatric pneumonia prevention and treatment by enhancing immune responses. This review synthesizes evidence on vitamin D
Area of Science:
- Pediatric immunology
- Nutritional science
- Respiratory medicine
Background:
- Pneumonia is a major global child health concern, particularly in resource-limited settings.
- Vitamin D deficiency is prevalent in children and linked to increased respiratory infection risk.
- This review examines vitamin D's role in pediatric pneumonia across different developmental stages.
Purpose of the Study:
- To synthesize current evidence on vitamin D's role in pediatric pneumonia.
- To explore vitamin D's impact on immune development and pneumonia risk in children.
- To provide an integrated perspective on vitamin D-mediated immune responses and clinical outcomes.
Main Methods:
- Comprehensive literature search across major scientific databases (PubMed, Scopus, Web of Science, Google Scholar).
- Screening of peer-reviewed articles including observational studies, RCTs, and reviews.
- Synthesis of evidence from immunology, genetics, maternal health, and microbiome research.
Main Results:
- Vitamin D enhances innate and adaptive immunity by inducing antimicrobial peptides, improving macrophage function, and modulating T-cell responses.
- Low serum 25-hydroxyvitamin D levels are consistently associated with increased pneumonia risk and severity.
- Factors like maternal status, VDR polymorphisms, and microbiome interactions influence vitamin D's efficacy.
Conclusions:
- Vitamin D biology is intrinsically linked to immune system development and pneumonia risk in children.
- Age-specific vitamin D supplementation strategies are crucial for effective prevention and management.
- Further mechanistic and clinical studies are needed to optimize vitamin D's role in pediatric pneumonia care.
Background:
Pneumonia remains a leading cause of morbidity and mortality among children globally, especially in low- and middle-income countries, where poor nutrition and limited access to healthcare increase vulnerability. Vitamin D deficiency is common among children and has emerged as a significant risk factor associated with respiratory infections. This review aims to synthesize current evidence on the role of vitamin D across developmental stages in pediatric pneumonia.
Methods:
A comprehensive literature search was conducted in PubMed, Scopus, Web of Science, and Google Scholar to identify relevant studies on vitamin D and pediatric pneumonia. Peer-reviewed articles, including observational studies, randomized controlled trials, and reviews, were screened. Evidence was synthesized from immunology, genetics, maternal health, and microbiome research to provide an integrated perspective on vitamin D-mediated immune responses and clinical outcomes.
Results:
Mechanistically, vitamin D enhances host defense by inducing antimicrobial peptides such as cathelicidin and β-defensins. It improves macrophage phagocytic function, modulates Toll-like receptor signaling, and preserves airway epithelial barrier integrity. Vitamin D also modulates adaptive immunity by suppressing pro-inflammatory Th1 and Th17 responses while promoting regulatory T-cell activity and anti-inflammatory cytokine production. Epidemiological studies consistently show an association between low serum 25-hydroxyvitamin D levels and increased risk and severity of pneumonia, although results from supplementation trials remain heterogeneous. Recent evidence highlights additional modifiers of vitamin D-mediated immunity, including maternal vitamin D status, vitamin D receptor (VDR) genetic polymorphisms, early-life immune programming, and respiratory microbiome interactions, which may explain variability in clinical outcomes across populations and developmental stages.
Conclusion:
Overall, this review provides a comprehensive framework linking vitamin D biology with immune system development in children and their risk of pneumonia. It emphasizes the importance of age-specific supplementation strategies and well-designed mechanistic and clinical studies to improve prevention and management.
Related Concept Videos
Development of Human Microbiota
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin D3(cholecalciferol).
Development of the Oral Microbiota
Pneumonia II: Pathophysiology
Pharmacokinetics in Pediatric Patients: Drug Metabolism

